Print Page  Close Window


SEC Filings

8-K
OREXIGEN THERAPEUTICS, INC. filed this Form 8-K on 04/02/2019
Entire Document
 


Case 18-10518-KG     Doc 1006     Filed 03/29/19     Page 7 of 11

 

In re: Orexigen Therapeutics, Inc.

   Case No. 18-10518 (KG)

Debtor

   Reporting Period: February 1, 2019 - February 28, 2019

 

MOR-1c

Schedule of Professional Fees and Expenses Paid

For the Period: February 1, 2019 - February 28, 2019

(Unaudited)

 

                                Month Ended 2/18/19                      Cumulative Since Filing      

Payee

  Category   Payor   Date   Period Covered   Fees     Expenses     Fees     Expenses  

 

 

Retained Professionals

               

Hogan Lovells US LLP

 

Debtor Counsel

 

Orexigen Therapeutics, Inc.            

  2/11/2019 3/12/2018 - 12/31/2018   $ 89,923     $ 437     $ 2,492,836     $ 33,877  

Morris, Nichols, Arsht & Tunnell LLP

 

Debtor Local Counsel

 

Orexigen Therapeutics, Inc.

  2/11/2019 3/12/2018  - 12/31/2018     32,602       203       807,272       22,295  

Ernst & Young, LLP

 

Debtor Financial Advisor

 

Orexigen Therapeutics, Inc.

  2/11/2019 3/12/2018  - 11/30/2018     49,605       -       2,151,260       202,314  

Perella Weinberg Partners

 

Debtor Investment Banker

 

Orexigen Therapeutics, Inc.

  3/12/2018  - 7/27/2018         3,411,713       3,600  

Irell & Manella LLP

 

Committee Counsel

 

Orexigen Therapeutics, Inc.

  2/11/2019 3/12/2018 - 11/30/2018     179,143       -       895,713       14,874  

Berkeley Research Group LLC

 

Committee Financial Advisor

 

Orexigen Therapeutics, Inc.

  2/11/2019 3/27/2018 - 11/30/2018     60,090       -       308,627       2,869  

Elliott Greenleaf, P.C.

 

Committee Local Counsel

 

Orexigen Therapeutics, Inc.

  2/11/2019 3/27/2018 - 11/30/2018     25,862       -       129,311       598  

Kurtzman Carson Consultants LLC

 

Claims Agent

 

Orexigen Therapeutics, Inc.

  2/11/2019 3/12/2018 - 12/31/2018     19,392       2,241       472,673       170,161  

Landis Rath & Cobb LLP

 

Debtor Conflict Counsel

 

Orexigen Therapeutics, Inc.

  2/11/2019 6/14/2018  - 11/30/2018     11,768       -       193,955       2,191  

Other Restructuring Professionals

               

Wilmington Trust, National Association

 

DIP Administrative Agent

 

Orexigen Therapeutics, Inc.

  3/12/2018 - 7/31/2018       $ 51,600     $ -  

Arnold & Porter Kaye Scholer LLP

 

DIP Administrative Agent Counsel

 

Orexigen Therapeutics, Inc.

  3/12/2018 - 7/27/2018         131,889       1,034  

Quinn Emanuel Urquhart & Sullivan, LLP    

 

DIP Lenders Counsel

 

Orexigen Therapeutics, Inc.

  3/12/2018 - 10/31/2018         1,023,973       19,636  

Brown Rudnick LLP

 

DIP Lender Counsel

 

Orexigen Therapeutics, Inc.

  2/15/2018  - 5/31/2018         147,048       1,497  

Whiteford Taylor Preston

 

DIP Lenders Local Counsel

 

Orexigen Therapeutics, Inc.

  1/24/2019 3/12/2018  - 12/31/2018         237,215       2,141  

U.S. Bank, N.A.

 

Indenture Trustee

 

Orexigen Therapeutics, Inc.

  2/25/2019 3/1/2018 - 1/31/2019     31,954       -       852,559       3,040  

Duane Morris

 

DTP Administrative Agent Secondary Counsel    

 

Orexigen Therapeutics, Inc.

  4/10/2018 - 7/27/2018         17,609       -  

 

 

Total

          $  500,338     $ 2,881     $ 13,325,253     $ 480,128